Company: MDCXW
Filing Date: 2025-06-23
Form Type: PRER14A
Source: 0001062993-25-012067
Chunk: 84

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-23
Form: PRER14A
Chunk 84
---
 rights attached to all outstanding voting securities of the Company other than voting securities held by the person or company as underwriter in the course of a distribution; and (d) the Company after having purchased, redeemed or otherwise acquired any of its securities, for so long as it holds any of its securities.

There are potential conflicts of interest to which all of the directors and officers of the Company may be subject in connection with the operations of the Company. All of the directors and officers are engaged in and will continue to be engaged in corporations or businesses, including publicly traded corporations, which may be in competition with the search by the Company for businesses or assets. Accordingly, situations may arise where all of the directors and officers will be in direct competition with the Company. Conflicts, if any, will be subject to the procedures and remedies as provided under the OBCA.

<div align='center'>MANAGEMENT CONTRACTS</div>

Management Agreement with RBx Capital, LP

The Company is party to a management agreement dated October 18, 2023 with RBx (the "Management Agreement").

<div align='center'>63</div>

Under the Management Agreement, RBx makes available to Medicus the following individuals to serve as management of the Company in the following capacities:

(a)Dr. Raza Bokhari, of Philadelphia, Pennsylvania, as Chief Executive Officer;

(b)Carolyn Bonner, of Philadelphia, Pennsylvania, as President; and

(c)Maryann Adesso, of Philadelphia, Pennsylvania, as Chief of Staff and Corporate Secretary of the Company.

In addition, RBx provides certain administrative, bookkeeping and IT supports to the Company. RBx also provides logistics and operational support in the form of:

(a)fully functional corporate offices and administrative assistance; and

(b)office equipment, which includes but is not limited to office furniture, computers and laptops, mobile phones devices, copiers, internet, audio & video equipment, etc.

As compensation for RBx's services, Medicus pays RBx a fee of $100,000 per month. Medicus also reimburses RBx for all reasonably necessary and usual business expenses incurred by RBx in connection with the Management Agreement.

Dr. Bokhari is the sole informed person of RBx. On May 3, 2024, Dr. Bokhari subscribed for $300,000 aggregate principal amount of 10.00% Unsecured Convertible Notes due 2025 from the Company on a private placement basis. Dr. Bokhari's 10.